These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 6435540

  • 1. [Enhancing effects on interferon-gamma production by combination of OK-432 and interferon-alpha in patients with head and neck cancer].
    Sugiyama M, Morisaki N, Konishi K, Go K, Sugita M, Nakai Y.
    Gan To Kagaku Ryoho; 1984 Oct; 11(10):2200-6. PubMed ID: 6435540
    [Abstract] [Full Text] [Related]

  • 2. [Antitumor effect of OK-432 (1)--antitumor effect of OK-432 induced interferon-gamma (IFN gamma)].
    Saito M, Yamaguchi T, Aonuma E, Noda T, Edina T, Ishida N.
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):2031-7. PubMed ID: 6820888
    [Abstract] [Full Text] [Related]

  • 3. [OK 432-induced production of IFN-gamma in peripheral mononuclear cells from healthy subjects and patients with cancer].
    Matsumoto H, Izutani R, Terada M, Noguchi J, Shiraha S, Kuyama T, Aoki N.
    Nihon Gan Chiryo Gakkai Shi; 1989 Apr 20; 24(4):751-8. PubMed ID: 2506311
    [Abstract] [Full Text] [Related]

  • 4. Synergistic therapeutic effect of combination therapy with OK-432 and interferon-alpha or -gamma on Meth-A ascites tumor in BALB/c mice.
    Mizushima Y, Morikage T, Hirata H, Sato M, Sakamoto K, Yano S.
    J Biol Response Mod; 1988 Aug 20; 7(4):371-83. PubMed ID: 3139841
    [Abstract] [Full Text] [Related]

  • 5. Production of tumor necrosis factor (TNF) by monocytes from cancer patients and healthy subjects induced by OK-432 in vitro, and its augmentation by human interferon gamma.
    Sekimoto M, Kokunai I, Shimano T, Kobayashi T, Takeda T, Haruna N, Yamamoto A, Mori T.
    J Clin Lab Immunol; 1988 Nov 20; 27(3):115-20. PubMed ID: 3150012
    [Abstract] [Full Text] [Related]

  • 6. Endogenous production of tumor necrosis factor in normal mice and human cancer patients by interferons and other cytokines combined with biological response modifiers of bacterial origin.
    Satoh M, Inagawa H, Shimada Y, Soma G, Oshima H, Mizuno D.
    J Biol Response Mod; 1987 Oct 20; 6(5):512-24. PubMed ID: 2445926
    [Abstract] [Full Text] [Related]

  • 7. Enhanced production of gamma-interferon by therapy with parenteral OK-432 and alpha-interferon in patients with head and neck cancer.
    Sugiyama M, Yamane H, Cho JS, Okada H, Sugita M, Nakai Y.
    Arch Otorhinolaryngol; 1986 Oct 20; 243(5):281-7. PubMed ID: 3101655
    [Abstract] [Full Text] [Related]

  • 8. Generation of activated killer-like cells by OK-432-mediated production of interleukin 1, interleukin 2, and interferon-gamma in vitro.
    Ujiie T.
    Jpn J Exp Med; 1987 Dec 20; 57(6):333-8. PubMed ID: 3131563
    [Abstract] [Full Text] [Related]

  • 9. [Sequential combination therapy with alpha interferon and OK-432 (streptococcal preparation) against advanced renal cell carcinoma].
    Marumo K, Mura M, Deguchi N, Baba S, Jitsukawa S, Nakazono M, Tazaki H.
    Gan To Kagaku Ryoho; 1986 Jul 20; 13(7):2434-9. PubMed ID: 3729498
    [Abstract] [Full Text] [Related]

  • 10. [Anticancer effects of OK-432 (2). Anticancer actions of M phi activated by OK-432].
    Saito M, Aonuma E, Noda T, Nakadate I, Nanjo M, Ebina T, Ishida N.
    Gan To Kagaku Ryoho; 1983 May 20; 10(5):1363-71. PubMed ID: 6870302
    [Abstract] [Full Text] [Related]

  • 11. A combination of cyclosporin-A (CsA) and interferon-gamma (INF-gamma) induces apoptosis in human gastric carcinoma cells.
    Morisaki T, Matsunaga H, Beppu K, Ihara E, Hirano K, Kanaide H, Mori M, Katano M.
    Anticancer Res; 2000 May 20; 20(5B):3363-73. PubMed ID: 11131636
    [Abstract] [Full Text] [Related]

  • 12. [Immunobiological studies of interferon-alpha A/D in comparison with a streptococcal preparation, OK-432].
    Mizushima Y, Hirata H, Sakamoto K, Sato M, Morikage T, Maruyama M, Sasaki K, Yano S.
    Gan To Kagaku Ryoho; 1987 Sep 20; 14(9):2710-5. PubMed ID: 3631971
    [Abstract] [Full Text] [Related]

  • 13. Priming effect of interferons and interleukin 2 on endogenous production of tumor necrosis factor in mice.
    Satoh M, Shimada Y, Inagawa H, Minagawa H, Kajikawa T, Oshima H, Abe S, Yamazaki M, Mizuno D.
    Jpn J Cancer Res; 1986 Apr 20; 77(4):342-4. PubMed ID: 2422147
    [Abstract] [Full Text] [Related]

  • 14. Streptococcal preparation OK-432 is a potent inducer of IL-12 and a T helper cell 1 dominant state.
    Fujimoto T, Duda RB, Szilvasi A, Chen X, Mai M, O'Donnell MA.
    J Immunol; 1997 Jun 15; 158(12):5619-26. PubMed ID: 9190909
    [Abstract] [Full Text] [Related]

  • 15. Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy.
    Okuse C, Rinaudo JA, Farrar K, Wells F, Korba BE.
    Antiviral Res; 2005 Jan 15; 65(1):23-34. PubMed ID: 15652968
    [Abstract] [Full Text] [Related]

  • 16. Interferon-alpha in serum and carcinomatous pleural effusion after repeated intrapleural injections of antitumor agents.
    Kaneto E, Sasaki H, Tamura I, Kurimura O, Kurimura T.
    Biken J; 1983 Jun 15; 26(2):99-102. PubMed ID: 6318725
    [Abstract] [Full Text] [Related]

  • 17. Involvement of Toll-like receptor 4 signaling in interferon-gamma production and antitumor effect by streptococcal agent OK-432.
    Okamoto M, Oshikawa T, Tano T, Ohe G, Furuichi S, Nishikawa H, Ahmed SU, Akashi S, Miyake K, Takeuchi O, Akira S, Moriya Y, Matsubara S, Ryoma Y, Saito M, Sato M.
    J Natl Cancer Inst; 2003 Feb 19; 95(4):316-26. PubMed ID: 12591988
    [Abstract] [Full Text] [Related]

  • 18. Anti-tumor immune response induced by the fractions derived from OK-432, a streptococcal preparation, by using a monoclonal antibody TS-2 that neutralizes the interferon-gamma-inducing activity of OK-432: comparison between the TS-2-binding and TS-2-unbinding fraction.
    Oshikawa T, Okamoto M, Ohe G, Furuichi S, Nishikawa H, Uddin Ahmed S, Yoshida H, Moriya Y, Matsubara S, Ryoma Y, Saito M, Sato M.
    Int Immunopharmacol; 2003 May 19; 3(5):643-55. PubMed ID: 12757734
    [Abstract] [Full Text] [Related]

  • 19. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.
    Okamoto M, Furuichi S, Nishioka Y, Oshikawa T, Tano T, Ahmed SU, Takeda K, Akira S, Ryoma Y, Moriya Y, Saito M, Sone S, Sato M.
    Cancer Res; 2004 Aug 01; 64(15):5461-70. PubMed ID: 15289356
    [Abstract] [Full Text] [Related]

  • 20. Effect of soluble factors derived from oral cancer cells on the production of interferon-γ from peripheral blood mononuclear cells following stimulation with OK-432.
    Ohe G, Sasai A, Uchida D, Tamatani T, Nagai H, Miyamoto Y.
    Oncol Rep; 2013 Aug 01; 30(2):945-51. PubMed ID: 23685791
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.